Latest Prescription Drugs news
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
posted June 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASCO: Asciminib Has Superior Efficacy to TKIs for Newly Diagnosed Leukemia
posted June 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Plozasiran Reduces Triglyceride Levels in Mixed Hyperlipidemia
posted June 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Donidalorsen Cuts Attack Rate in Hereditary Angioedema
posted June 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
